Pathological Comparisons of Surgical Open Lung Biopsies and Cryobiopsies in Non-IPF ILD
CryoPID
Le rôle de la Cryobiopsie Transbronchique Dans le Diagnostic Des Maladies Pulmoniares Interstitielles
2 other identifiers
interventional
21
2 countries
2
Brief Summary
Pathological comparisons of surgical open lung biopsies and cryobiopsies in non-IPF ILD. Patients with non-IPF ILD eligible for an open lung biopsy will undergo cryobiopsy in the same time. Between observers agreement will be assessed for each pairs of samples.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2016
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 20, 2016
CompletedFirst Submitted
Initial submission to the registry
April 13, 2016
CompletedFirst Posted
Study publicly available on registry
May 5, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 25, 2018
CompletedMarch 19, 2021
March 1, 2021
2.2 years
April 13, 2016
March 16, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The percentage of concordant diagnoses between cryobiopsy and surgical lung biopsy.
The gold standard is the consensual diagnosis between the two readers established from surgical biopsy
for statistical analysis, 12 months after the first inclusion
Secondary Outcomes (5)
The percentage homology between diagnosis obtained by surgical biopsy and cryobiopsy with the multidisciplinary approach
one day after inclusion
The percentage homology intra and inter observer for histopathological analysis of each type of sample by Mac Nemar test
for statistical analysis, 12 months after the first inclusion
The number of elementary lesions actually present in the two samples for the same patient
One day after inclusion
The time of the gesture and the respective anesthetic complexities of each procedure
One day after inclusion
The rate of adverse events
for statistical analysis, 12 months after the first inclusion
Study Arms (1)
Lung cryobiopsy
OTHERInterventions
Eligibility Criteria
You may qualify if:
- Non IPF ILD eligible for surgical lung biopsy reviewed during multidisciplinary approach
You may not qualify if:
- Ineligible for lung biopsy: pulmonary hypertension, coagulation deficiency, FEV\<11, giant emphysematous bullae, hemodynamic instability severe hypoxia, general anesthetic ineligibility
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Arnaud de Villeneuve University Hospital
Montpellier, 34295, France
S'Orsola-Malpighi hospital
Bologna, 40138, Italy
Related Publications (6)
Romagnoli M, Colby TV, Suehs CM, Vachier I, Molinari N, Bourdin A. Cryobiopsy Compared with Surgical Lung Biopsy in ILD: Reply to Maldonado et al., Froidure et al., Bendstrup et al., Agarwal et al., Richeldi et al., Rajchgot et al., and Quadrelli et al. Am J Respir Crit Care Med. 2019 Oct 1;200(7):944-946. doi: 10.1164/rccm.201906-1252LE. No abstract available.
PMID: 31442081BACKGROUNDBourdin A, Suehs CM, Colby TV, Vachier I, Molinari N, Romagnoli M. Reply to Wand et al.: Role of Transbronchial Cryobiopsy in Interstitial Lung Diseases: An Ongoing Tale. Am J Respir Crit Care Med. 2020 Jan 15;201(2):260-261. doi: 10.1164/rccm.201909-1736LE. No abstract available.
PMID: 31535900BACKGROUNDBourdin A, Romagnoli M, Gamez AS, Hireche K, Berthet JP, Mallet JP, Vachier I, Nava S, Reynaud P, Molinari N, Suehs C. Careful consideration of the bleeding caused by transbronchial lung cryobiopsies. Eur Respir J. 2020 May 21;55(5):1902415. doi: 10.1183/13993003.02415-2019. Print 2020 May. No abstract available.
PMID: 32439734BACKGROUNDRomagnoli M, Colby TV, Berthet JP, Gamez AS, Mallet JP, Serre I, Cancellieri A, Cavazza A, Solovei L, Dell'Amore A, Dolci G, Guerrieri A, Reynaud P, Bommart S, Zompatori M, Dalpiaz G, Nava S, Trisolini R, Suehs CM, Vachier I, Molinari N, Bourdin A. Poor Concordance between Sequential Transbronchial Lung Cryobiopsy and Surgical Lung Biopsy in the Diagnosis of Diffuse Interstitial Lung Diseases. Am J Respir Crit Care Med. 2019 May 15;199(10):1249-1256. doi: 10.1164/rccm.201810-1947OC.
PMID: 30864813RESULTSuehs C, Bourdin A, Vachier I, Molinari N, Romagnoli M. Transbronchial cryobiopsy in the diagnosis of interstitial lung diseases: methodologies and perspectives from the Cryo-PID and COLDICE studies. Ann Transl Med. 2020 Oct;8(20):1330. doi: 10.21037/atm-20-2814. No abstract available.
PMID: 33209910RESULTReynaud P, Ahmed E, Serre I, Knabe L, Bommart S, Suehs C, Vachier I, Berthet JP, Romagnoli M, Vernisse C, Mallet JP, Gamez AS, Bourdin A. Club Cell Loss as a Feature of Bronchiolization in ILD. Front Immunol. 2021 Feb 26;12:630096. doi: 10.3389/fimmu.2021.630096. eCollection 2021.
PMID: 33717159RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Arnaud Bourdin, MD, PhD
University Hospitals of Montpellier
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 13, 2016
First Posted
May 5, 2016
Study Start
January 20, 2016
Primary Completion
March 30, 2018
Study Completion
June 25, 2018
Last Updated
March 19, 2021
Record last verified: 2021-03